(Q53317312)

13 May 2018

title

Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. (English)

1 reference

13 May 2018

7

Wagner F Gattaz

1 reference

13 May 2018

author name string

Evelin L Schaeffer

1

1 reference

13 May 2018

Vanessa J De-Paula

2

1 reference

13 May 2018

Emanuelle R da Silva

3

1 reference

13 May 2018

Barbara de A Novaes

4

1 reference

13 May 2018

Heni D Skaf

5

1 reference

13 May 2018

Orestes V Forlenza

6

1 reference

13 May 2018

publication date

9 March 2011

1 reference

13 May 2018

Journal of Neural Transmission

published in

1 reference

13 May 2018

volume

118

1 reference

13 May 2018

issue

9

1 reference

13 May 2018

page(s)

1273-1279

1 reference

13 May 2018

SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The growing phospholipase A2 superfamily of signal transduction enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Decreased phospholipase A2 activity in Alzheimer brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Differential assembly of human tau isoforms in the presence of arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The C2 domain calcium-binding motif: structural and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Both total and phosphorylated tau are increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Molecular characterization of cytosolic phospholipase A2-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain

21 January 2018

1 reference

12 December 2020

Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia

1 reference

12 December 2020

Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease

1 reference

12 December 2020

Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory

1 reference

12 December 2020

Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

1 reference

12 December 2020

Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability.

1 reference

12 December 2020

Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2

1 reference

12 December 2020

Phospholipase A2 structure/function, mechanism, and signaling

1 reference

12 December 2020

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

1 reference

12 December 2020

A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex

1 reference

12 December 2020

Diversity of group types, regulation, and function of phospholipase A2

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity

1 reference

12 December 2020

10.1007/S00702-011-0619-4

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018